NORTHERN TRUST CORP - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,519,457
+6.3%
518,586
+3.7%
0.00%
Q2 2023$1,430,023
-4.7%
500,008
+2.9%
0.00%
Q1 2023$1,501,236
+39.5%
485,837
-4.7%
0.00%
Q4 2022$1,075,894
+39.9%
509,902
+116.4%
0.00%
Q3 2022$769,000
-1.0%
235,642
-2.8%
0.00%
Q2 2022$777,000
-9.9%
242,389
+98.5%
0.00%
Q1 2022$862,000
-4.3%
122,089
-1.8%
0.00%
Q4 2021$901,000124,3760.00%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders